Keywords
Affiliated Institutions
Related Publications
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
The angiotensin-II-receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the re...
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
Captopril protects against deterioration in renal function in insulin-dependent diabetic nephropathy and is significantly more effective than blood-pressure control alone.
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
Chronic treatment of saline-drinking stroke-prone spontaneously hypertensive rats (SHRSP) with agents that interfere with the formation or actions of angiotensin II (Ang II) pre...
Standards of Medical Care in Diabetes—2007
Cardiovascular disease 1. Hypertension/blood pressure control 2. Dyslipidemia/lipid management 3. Antiplatelet agents 4. Smoking cessation 5. C o r o n a r y h e a r t d i s e a...
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
Background and Purpose— Statins have been shown conclusively to reduce the risk of cardiovascular events in subjects with clinical cardiovascular disease or diabetes aged 65 to ...
Publication Info
- Year
- 2002
- Type
- article
- Volume
- 11
- Issue
- 1
- Pages
- 26-26
- Citations
- 511
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1016/s1062-1458(01)00549-9